Strategic Partnership Aims to Boost Kidney Care for Patients

Spherix Global Insights Partners with the American Kidney Fund

EXTON, PA – Spherix Global Insights announces an exciting partnership with the American Kidney Fund (AKF), creating a landmark collaboration to improve kidney care for patients. This strategic alliance merges Spherix's exceptional market intelligence capabilities with AKF's esteemed patient advocacy efforts, focusing on addressing the numerous unmet needs within the renal community.

Inaugural Initiative: Patient Dynamix™ on IgA Nephropathy

The first research project launched under this partnership, called Patient Dynamix™: IgA Nephropathy (US), aims to gather insights directly from patients affected by this rare but serious condition. IgA Nephropathy (IgAN) is increasingly recognized as one of the leading causes of kidney disease, and many patients may progress to end-stage renal disease (ESRD). Understanding the patient experience is crucial for shaping effective care strategies and promoting timely interventions to mitigate disease progression.

Patient Engagement in Healthcare

Meghan Weiss, head of the Spherix Nephrology Franchise, emphasized the importance of understanding the challenges faced by these patients: "Now, more than ever, it is vital for healthcare companies to engage with patient communities to fully grasp the breadth of challenges they face. Through this research, we aim to bridge gaps in understanding and amplify the patient voice in IgAN treatment and care." This highlights the pressing need for healthcare solutions that truly resonate with patient experiences and preferences.

Understanding the Growing Concern of IgAN

LaVarne A. Burton, President and CEO of AKF, stated, "In recent years we have seen an increasing prevalence of IgAN – a concerning trend for this serious and life-altering condition. With new therapies emerging and further research anticipated, our collaboration with Spherix represents a significant step toward addressing the unmet needs in treating and managing IgAN." This partnership aims to address both immediate and long-term challenges faced by individuals dealing with this condition.

Exploring Patient Experiences

Through this research initiative, Spherix and AKF will delve into various facets of the IgAN patient journey, producing valuable insights such as:

• Patient demographics, health perceptions, and disease progression
• Experiences surrounding diagnosis and evaluations of quality of life
• Preferences and behaviors concerning treatment information-seeking
• Interactions and challenges with insurance providers
• Support desires from healthcare teams and pharmaceutical entities
• Current treatment experiences with therapies like budesonide, sparsentan, and iptacopan
• Patient preferences regarding new treatment formats and methods of administration

Leveraging Expertise for Better Outcomes

This partnership intends to make the most of AKF's position as a leading patient advocacy organization, combined with Spherix’s expertise in rare renal diseases. The goal is to convert this collaborative effort into actionable data that can empower stakeholders, enhancing patient experiences and raising standards of care within the kidney health sector.

About Spherix Global Insights

Spherix is recognized as an independent leader in market intelligence and advisory services, delivering substantial commercial value across the global life sciences landscape. With a dedicated team of experts, Spherix offers a comprehensive view of rapidly evolving specialty markets such as nephrology, among others. Their reliable insights and advisory services enable clients to make well-informed decisions, fostering growth opportunities.

About the American Kidney Fund

AKF plays a pivotal role in addressing kidney disease nationwide. As a nonprofit organization with a profound impact on the lives of individuals living with kidney disease, AKF supports prevention, disease management, financial assistance, clinical research, and policy advocacy. Their unparalleled commitment ensures that significant portions of every donation go directly to programs that benefit patients, maintaining high ratings from entities like Charity Navigator and Candid.

To learn more about the partnership, please reach out to:

Spherix Global Insights Contacts

Meghan Weiss, Nephrology Franchise Head

Meghan.weiss@spherixglobalinsights.com

American Kidney Fund Contacts

Nancy Gregory, Senior Director of Communications

ngregory@kidneyfund.org

Frequently Asked Questions

What is the purpose of the Spherix and AKF partnership?

The collaboration aims to improve kidney care by integrating market intelligence with patient advocacy, focusing on enhancing the treatment and management of IgAN.

What is IgA Nephropathy?

IgA Nephropathy is a kidney condition characterized by the accumulation of IgA antibodies in the kidney, which can lead to kidney damage and eventually renal failure.

How will this research benefit kidney patients?

The research will provide insights into the patient experience, informing better treatment options and support structures for those living with IgAN.

Who is leading the initiative at Spherix?

Meghan Weiss oversees the nephrology franchise at Spherix Global Insights, playing a crucial role in the initiative.

How does AKF support kidney patients?

AKF offers various programs for kidney disease prevention, management, financial aid, and advocacy, helping individuals navigate their health journeys.

About The Author

Dedicated Author and financial expert Logan Wright here, 29 years old. After earning an economics degree, I spent a number of years working in different financial industries. My great passion is enabling everyone, from any background or experience level, to understand and be literate in financial matters.

My books and writings are centered on simplifying difficult financial ideas into doable, understandable guidance. Whether it's retirement planning, investing, or budgeting, I want to arm readers with the information they need to make wise financial choices and realize their financial objectives.

Apart from writing, I also frequently post to financial blogs and organize webinars and workshops targeted at enlightening participants about personal finance. Always, my strategy is to offer concise, doable advice that can truly improve people's lives.

Away from work, I like to read, travel, and sample new foods. My goal is to infuse everything I do with the balance that I think is essential to both financial and personal well-being. By my profession, I want to encourage and enable people to confidently and clearly take charge of their financial futures.

Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.